Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2).
Saved in:
| Title: | Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2). |
|---|---|
| Authors: | Duncan P; Centre for Academic Primary Care, University of Bristol, Bristol, UK polly.duncan@bristol.ac.uk.; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Mears R; Centre for Academic Primary Care, University of Bristol, Bristol, UK.; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Begier E; Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US., Rouhbakhsh Halvaei S; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Southern J; Evidence Generation, Pfizer Inc, Collegeville, PA, US., Porter SB; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Hubler R; Evidence Generation, Pfizer Inc, Collegeville, PA, US., Oben G; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Qian G; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Lahuerta M; Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US., Davis T; Centre for Academic Primary Care, University of Bristol, Bristol, UK., Campling J; Vaccines Medical Affairs, Pfizer Ltd, Tadworth, UK., Dawson S; Centre for Academic Primary Care, University of Bristol, Bristol, UK., Christensen H; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Oliver J; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Morales-Aza B; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Pan K; EvGen Statistics, Pfizer Research and Development, Pfizer Inc, Collegeville, PA, US., Gray S; Evidence Generation, Pfizer Inc, Collegeville, PA, US., Hyams C; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Danon L; School of Engineering Mathematics and Technology, University of Bristol, Bristol, UK., Gessner BD; Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US.; West of England NIHR Clinical Research Network, Bristol, UK., Finn A; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Hay AD; Centre for Academic Primary Care, University of Bristol, Bristol, UK. |
| Corporate Authors: | AvonCAP GP2 research group |
| Source: | BJGP open [BJGP Open] 2025 Jan 02; Vol. 8 (4). Date of Electronic Publication: 2025 Jan 02 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Royal College of General Practitioners Country of Publication: England NLM ID: 101713531 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 2398-3795 (Electronic) Linking ISSN: 23983795 NLM ISO Abbreviation: BJGP Open Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39251234 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Duncan+P%22">Duncan P</searchLink>; Centre for Academic Primary Care, University of Bristol, Bristol, UK polly.duncan@bristol.ac.uk.; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Mears+R%22">Mears R</searchLink>; Centre for Academic Primary Care, University of Bristol, Bristol, UK.; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Begier+E%22">Begier E</searchLink>; Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US.<br /><searchLink fieldCode="AU" term="%22Rouhbakhsh+Halvaei+S%22">Rouhbakhsh Halvaei S</searchLink>; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Southern+J%22">Southern J</searchLink>; Evidence Generation, Pfizer Inc, Collegeville, PA, US.<br /><searchLink fieldCode="AU" term="%22Porter+SB%22">Porter SB</searchLink>; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Hubler+R%22">Hubler R</searchLink>; Evidence Generation, Pfizer Inc, Collegeville, PA, US.<br /><searchLink fieldCode="AU" term="%22Oben+G%22">Oben G</searchLink>; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Qian+G%22">Qian G</searchLink>; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Lahuerta+M%22">Lahuerta M</searchLink>; Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US.<br /><searchLink fieldCode="AU" term="%22Davis+T%22">Davis T</searchLink>; Centre for Academic Primary Care, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Campling+J%22">Campling J</searchLink>; Vaccines Medical Affairs, Pfizer Ltd, Tadworth, UK.<br /><searchLink fieldCode="AU" term="%22Dawson+S%22">Dawson S</searchLink>; Centre for Academic Primary Care, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Christensen+H%22">Christensen H</searchLink>; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Oliver+J%22">Oliver J</searchLink>; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Morales-Aza+B%22">Morales-Aza B</searchLink>; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Pan+K%22">Pan K</searchLink>; EvGen Statistics, Pfizer Research and Development, Pfizer Inc, Collegeville, PA, US.<br /><searchLink fieldCode="AU" term="%22Gray+S%22">Gray S</searchLink>; Evidence Generation, Pfizer Inc, Collegeville, PA, US.<br /><searchLink fieldCode="AU" term="%22Hyams+C%22">Hyams C</searchLink>; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Danon+L%22">Danon L</searchLink>; School of Engineering Mathematics and Technology, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Gessner+BD%22">Gessner BD</searchLink>; Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US.; West of England NIHR Clinical Research Network, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Finn+A%22">Finn A</searchLink>; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Hay+AD%22">Hay AD</searchLink>; Centre for Academic Primary Care, University of Bristol, Bristol, UK. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22AvonCAP+GP2+research+group%22">AvonCAP GP2 research group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101713531%22">BJGP open</searchLink> [BJGP Open] 2025 Jan 02; Vol. 8 (4). <i>Date of Electronic Publication: </i>2025 Jan 02 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Royal+College+of+General+Practitioners%22">Royal College of General Practitioners </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101713531 <i>Publication Model: </i>Electronic-Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2398-3795 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223983795%22">23983795 </searchLink><i>NLM ISO Abbreviation: </i>BJGP Open <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39251234 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3399/BJGPO.2024.0129 Languages: – Code: eng Text: English Titles: – TitleFull: Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Duncan P – PersonEntity: Name: NameFull: Mears R – PersonEntity: Name: NameFull: Begier E – PersonEntity: Name: NameFull: Rouhbakhsh Halvaei S – PersonEntity: Name: NameFull: Southern J – PersonEntity: Name: NameFull: Porter SB – PersonEntity: Name: NameFull: Hubler R – PersonEntity: Name: NameFull: Oben G – PersonEntity: Name: NameFull: Qian G – PersonEntity: Name: NameFull: Lahuerta M – PersonEntity: Name: NameFull: Davis T – PersonEntity: Name: NameFull: Campling J – PersonEntity: Name: NameFull: Dawson S – PersonEntity: Name: NameFull: Christensen H – PersonEntity: Name: NameFull: Oliver J – PersonEntity: Name: NameFull: Morales-Aza B – PersonEntity: Name: NameFull: Pan K – PersonEntity: Name: NameFull: Gray S – PersonEntity: Name: NameFull: Hyams C – PersonEntity: Name: NameFull: Danon L – PersonEntity: Name: NameFull: Gessner BD – PersonEntity: Name: NameFull: Finn A – PersonEntity: Name: NameFull: Hay AD IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 01 Text: 2025 Jan 02 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2398-3795 Numbering: – Type: volume Value: 8 – Type: issue Value: 4 Titles: – TitleFull: BJGP open Type: main |
| ResultId | 1 |
